ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,054Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 1006

$541K Total Retail Price of All Prescriptions

Rank: 197 out of 1006

493 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 493 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 493 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,458 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 427 335 1 1
LISINOPRIL 406 341 2 3
FUROSEMIDE 315 287 3 6
AMLODIPINE BESYLATE 295 266 4 4
METOPROLOL TARTRATE 262 244 5 7
LEVOTHYROXINE SODIUM 261 222 6 2
METFORMIN HCL 251 178 7 10
OMEPRAZOLE 222 219 8 9
WARFARIN SODIUM 213 157 9 8
METOPROLOL SUCCINATE 170 168 10 12
ATORVASTATIN CALCIUM 168 125 11 5
DIOVAN 137 107 12 16
TAMSULOSIN HCL 116 112 13 23
ATENOLOL 111 100 14 13
ZOLPIDEM TARTRATE 95 77 15 14
HYDROCHLOROTHIAZIDE 95 91 15 11
SERTRALINE HCL 90 72 17 19
LANTUS 88 72 18 43
GLIPIZIDE 87 74 19 69
DIGOXIN 85 79 20 52
CITALOPRAM HBR 82 82 21 24
GEMFIBROZIL 82 55 21 159
PAROXETINE HCL 79 49 23 62
CARVEDILOL 75 63 24 36
MIRTAZAPINE 74 74 25 26
LACTULOSE 73 63 26 104
DONEPEZIL HCL 73 73 26 17
ALENDRONATE SODIUM 72 58 28 29
ENALAPRIL MALEATE 71 71 29 83
QUETIAPINE FUMARATE 69 53 30 45
OLANZAPINE 69 36 30 68
HYDRALAZINE HCL 67 38 32 100
ACTOS 67 46 32 89
RISPERIDONE 66 28 34 40
BENZTROPINE MESYLATE 65 28 R 35 106
ALLOPURINOL 65 60 35 31
POTASSIUM CHLORIDE 65 57 35 30
NEXIUM 64 60 38 28
PLAVIX 62 55 39 61
DOXAZOSIN MESYLATE 59 59 40 87
LIPITOR 58 56 41 47
TRICOR 56 42 42 101
CLOPIDOGREL 53 45 43 46
TRAVATAN Z 53 50 43 131
CLOZAPINE 50 0 45 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.